PROCEPT BioRobotics has developed the AQUABEAM® Robotic System which delivers Aquablation® therapy. The AQUABEAM Robotic System is the first surgical robot providing autonomous tissue removal for the treatment of BPH. Aquablation therapy is a technique that combines the clarity of real-time, multi-dimensional imaging, autonomous robotics and heat-free waterjet ablation for targeted, controlled, and immediate removal of prostate tissue for the treatment of lower urinary tract symptoms (LUTS) caused by BPH. Aquablation therapy is designed to break the tradeoff in BPH treatment between efficacy and negative side effects. Results of the company’s two global clinical studies have proven that patients with any size prostate can have access to an outpatient transurethral procedure that result in large symptom benefits with significantly less risk of sexual complications that permanently impact their quality of life